SALT LAKE CITY, Sept. 21, 2018 /PRNewswire-PRWeb/ -- Today, Leavitt Risk Partners announced that the firm will be
Leveraging its proprietary BLISCare methodology, Leavitt Risk Partners evaluates and quantifies the risk of medical outcomes. Through the BLISCare Outcome-Based Performance Guarantee, Leavitt Risk Partners enables medical technology companies to analyze, develop, and deploy guarantees around the performance of their products.
"Patients don't buy devices, they buy outcomes. Value-based care is encouraging that medical technology companies compete on value and outcomes versus simply volume and price. BLISCare can help these companies compete on that level," according to Phil Harker, chief executive officer and president of Leavitt Risk Partners.
As the health care industry continues to transition toward value-based payment arrangements, it is essential for each industry sector to substantiate how they are contributing to providing higher quality care at lower costs. Equipped with the BLISCare Outcome-Based Performance Guarantee, medical technology companies can be viewed as a value provider, improve patient outcomes, and drive differentiation in the market place.
Leavitt Risk Partners looks forward to discussing this innovative solution at the MedTech Conference and invites interested vendors to visit the exhibit during the conference.
About Leavitt Risk Partners Leavitt Risk Partners (LRP), formerly BLIS, Inc., produces more positive health outcomes by enabling the sharing of risk. LRP is part of the Leavitt Partners family of businesses and is headquartered in Salt Lake City, UT. Since 2005, LRP has utilized its BLISCare proprietary methodology focused on articulating and quantifying the risks associated with clinical outcomes to bring new and innovative products to the health care marketplace. From this methodology, LRP has developed three solutions that address outcomes risk: Surgical Complications Risk Protection, Surgical Bundle Protection, and Outcomes-Based Performance Guarantees. Learn more at http://www.leavittriskpartners.com
SOURCE Leavitt Partners
Subscribe to our Free Newsletters!
FDA approved elapegademase-lvlr injection for intramuscular use is used as an enzyme replacement ...
Armpit lumps and raised bumps in the armpits caused by infection, cysts and other types of ...
Bad eating habits will affect your health as well as your skin and make you look older than your ...View All